ArticleBlood cancer journal2026

Pre-transplant molecular international prognostic scoring system score reduction is not associated with improved outcomes in myelodysplastic syndromes.

Masataka Sakashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.